Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
366.51M | 408.37M | 385.37M | 250.16M | 247.10M | Gross Profit |
62.10M | 80.01M | 91.53M | 45.10M | 43.44M | EBIT |
26.14M | 43.70M | 58.16M | 19.04M | 16.00M | EBITDA |
34.73M | 48.94M | 62.30M | 22.84M | 19.69M | Net Income Common Stockholders |
22.66M | 35.92M | 35.92M | 14.98M | 12.48M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
75.88M | 62.61M | 37.03M | 28.62M | 16.95M | Total Assets |
269.70M | 250.36M | 224.81M | 167.35M | 154.08M | Total Debt |
8.67M | 6.60M | 5.00M | 4.85M | 5.63M | Net Debt |
-67.21M | -56.01M | -32.03M | -23.77M | -11.32M | Total Liabilities |
54.47M | 54.78M | 60.84M | 45.53M | 49.81M | Stockholders Equity |
215.23M | 195.57M | 163.97M | 121.82M | 104.28M |
Cash Flow | Free Cash Flow | |||
21.54M | 33.01M | 16.35M | 16.16M | 5.79M | Operating Cash Flow |
27.13M | 36.31M | 20.66M | 18.13M | 9.67M | Investing Cash Flow |
-5.53M | -2.41M | -6.47M | -1.95M | -4.23M | Financing Cash Flow |
-8.33M | -8.32M | -5.79M | -4.51M | -4.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £63.51B | 20.79 | 15.72% | 1.60% | 2.11% | 3.37% | |
77 Outperform | £4.25B | 19.52 | 4.92% | 7.93% | -3.22% | -37.21% | |
73 Outperform | £404.38M | 23.10 | 8.09% | 1.56% | -0.61% | 34.19% | |
71 Outperform | £210.84M | ― | ― | ― | ― | ||
64 Neutral | $4.24B | 11.64 | 5.23% | 249.83% | 4.07% | -10.54% | |
63 Neutral | £740.01M | 48.91 | 3.80% | 2.71% | -9.77% | -28.49% |